Basics Revolution Medicines, Inc. IPO Date: February 13, 2020 Sector: Healthcare Industry: Biotech Market Cap: $10B Activated in VL: True Average Daily Range Avg Daily Range: $0.82 | 2.67% Avg Daily Range (30 D): $0.91 | 1.96% Avg Daily Range (90 D): $0.73 | 1.77% Institutional Daily Volume Avg Daily Volume: .87M Avg Daily Volume (30 D): 1.81M Avg Daily Volume (90 D): 1.69M Trade Size Avg Trade Size (Sh.): 70 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 4,770 Avg Inst. Trade: $3.16M Avg Inst. Trade (30 D): $4.4M Avg Inst. Trade (90 D): $4.72M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $6.01M Avg Closing Trade (30 D): $12.74M Avg Closing Trade (90 D): $14.5M Avg Closing Volume: 181.84K     News Sep 29, 2025 @ 1:00 PM Revolution Medicines Announces Key Leadership Addi... Source: Revolution Medicines Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D. Aug 6, 2025 @ 12:25 AM Tango (TNGX) Q2 Revenue Drops 52% Source: Na Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics May 27, 2025 @ 1:00 PM rEvolution Appoints Brian Gabriel as Vice Presiden... Source: Globe Newswire Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.52 $-1.31 $-1.13 Diluted EPS $-4.52 $-1.31 $-1.13 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -812.06M $ -247.79M $ -213.42M Operating Income / Loss $ -897.5M $ -264.71M $ -240.76M Cost of Revenue $ $ $ Net Cash Flow $ 127.61M $ 69.1M $ -209.51M PE Ratio